Mometasonfuroaat Teva (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasonfuroaat Teva, is a corticosteroid presented as a nasal spray for endosinusial use. It is employed to manage inflammatory nasal conditions such as allergic rhinitis in both adults and children.

GNH USA supplies Mometasonfuroaat Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate nasal spray is used to treat inflammatory conditions of the nasal passages by reducing local immune response. - Allergic rhinitis: alleviates nasal congestion, itching, sneezing and rhinorrhea. - Nasal polyposis (post‑surgical): helps prevent recurrence of polyps after endoscopic sinus surgery. - Non‑allergic rhinitis: reduces nasal inflammation and improves airflow.

Mometasone furoate nasal spray may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation. - Epistaxis (nosebleeds). - Headache. - Throat dryness. - Cough. - Unpleasant taste.

Serious or Rare Side Effects: - Nasal septal perforation. - Secondary fungal or bacterial infections of the nasal cavity. - Elevated intra‑ocular pressure or glaucoma. - Adrenal suppression with prolonged high‑dose use. - Systemic corticosteroid effects such as hyperglycemia.

Before using Mometasone furoate nasal spray, consider the following safety measures. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: discuss potential risks with a physician. - Existing infections: avoid use if active nasal or sinus infections are present. - Surgery: discontinue prior to nasal or sinus surgery to reduce bleeding risk. - Long‑term use: monitor for signs of adrenal suppression or ocular pressure changes. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Mometasone furoate nasal spray can interact with other medications that affect corticosteroid metabolism or increase infection risk.

Major Interactions (Avoid): - Systemic CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) that may increase systemic exposure. - Live vaccines: concurrent use may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antifungal agents (e.g., fluconazole) that modestly raise corticosteroid levels. - Immunosuppressants (e.g., azathioprine) that may heighten infection risk. - Nasal decongestants: combined use may increase local irritation. - Other intranasal corticosteroids: avoid duplicate therapy to prevent excess exposure.